Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-865P is a pseudogene belonging to the U6 small nuclear RNA (snRNA) gene family. U6 snRNA is a component of the spliceosome complex and is essential for pre-mRNA splicing in eukaryotes[1][3]. However, RNU6-865P specifically is annotated as a *pseudogene*, meaning it is a genomic sequence similar to the functional U6 snRNA gene but is presumed to be nonfunctional due to mutations or a lack of necessary regulatory elements for expression[2][5]. Pseudogenes like RNU6-865P are abundant in the human genome and can sometimes play roles in gene regulation (for instance, as competing endogenous RNAs for microRNAs in certain pathological contexts), but there is no specific evidence that RNU6-865P is functional or disease-associated at present[4]. It is not considered a conventional therapeutic target and is not known to interact with any drugs.\n\nIf you require structured information for functional U6 snRNA, note that its canonical role is a core catalytic component of the spliceosome, but that does not apply to this pseudogene[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 865, pseudogene (RNU6-865P).